Monday 4 April 2016

Bombay HC raps Indian drug manufacturing company for alleged spurious anti-cancer drug export

The Bombay High Court lamented about the "disastrous effect on public health due to trafficking in illicit drugs" in an ongoing trademark infringement case reported the Times of India

The case, which was filed by Emcure, a pharmaceutical company against Taj Pharmaceuticals regarding trademark violation resulted in the court attaching the properties of Taj Pharma. Taj Pharma's directors have now declared to the court that they will abstain from exporting any pharmaceutical preparation of any nature, till the court decides the matter, which has now been posted for April 20 for final disposal, it was reported.

Emcure Pharma has alleged that Taj Pharma has been selling counterfeit drugs made in India to treat brain tumour, overseas using their trademark. The allegations were denied by Taj.

The court observed that jeopardizing public safety through these spurious drugs is a much bigger concern than trademark violation and financial loss to Emcure. The court also observed that had these spurious drugs reached their intended targets, there would have been certain fatalities because of their usage. 

Web screenshot of Taj Pharmaceuticals

The Court was not inclined to believe the statements made by Taj as they had already admitted that the claims on their websites are untrue and realizing the gravity of the issue, posted the matter to April 30, TOI reported.

No comments:

Post a Comment